Two decades ago, when Fred Hutch, the University of Washington and Seattle Children’s formed a consortium, they created the Seattle Cancer Care Alliance to serve as a hub of clinical operations.
Twenty years ago, when Fred Hutch, the University of Washington and Seattle Children’s created a united cancer program in Seattle, they relied on an entity called Seattle Cancer Care Alliance to deliver the consortium’s clinical services.
When Peter Pisters returned to The University of Texas System as president of MD Anderson Cancer Center in December 2017, one of his top priorities included achieving gender parity and diversifying the hospital’s executive suite.
A House appropriations subcommittee voted to increase NIH’s FY2022 budget by $6.5 billion—to $46.43 billion—which falls $2.5 billion short of President Joe Biden’s request for NIH.
On April 25, 1991, speaking to the Senate Labor and Human Resources Committee, Sen. Edward M. Kennedy opened the National Cancer Act’s 20th anniversary hearing with praise for advances in research, concerns about cancer disparities, and a battle cry: “The War on Cancer is far from won.”
Over the past year, we have witnessed the awesome power of American pharmaceutical and biotechnology companies.
It’s safe to say that July 1 was a better than average day for Suresh S. Ramalingam.
The FY22 budget proposed by the White House doesn’t include sufficient funds to sustainably support NCI researchers, even though the proposal includes the largest ever funding increase for NIH, the American Association for Cancer Research said in a letter to House appropriators.
From 2015 to 2018, the overall cancer death rate in the United States fell by 2.3% per year for men and 2.1% per year for women—an unprecedented drop, led by accelerated decline in deaths from lung cancer and melanoma.
Two academic health systems in Cleveland are creating programs and faculty positions to direct institutional initiatives on health equity—at the executive level.
